<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M820</article-id>
      <article-id pub-id-type="publisher-id">molbank-2014-M820</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>2-(4-(2-Chloroacetamido)-1-methyl-1<italic>H</italic>-pyrrole-2-carboxamido)ethyl Acetate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Said</surname>
            <given-names>Naim H.</given-names>
          </name>
          <xref rid="af1-molbank-2014-M820" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2014-M820" ref-type="aff">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2014-M820"><label>1</label>Department of Chemistry, Jordan University of Science and Technology, Irbid 22110, Jordan</aff>
      <aff id="af2-molbank-2014-M820"><label>2</label>College of Applied Medical Sciences-Al Ahsa, King Saud bin Abdulaziz University for Health Sciences, Al-Ahsa 31982, Kingdom of Saudi Arabia; E-Mail: <email>saidn@ksau-hs.edu.sa</email>; Tel.: +00966-13-562-9000 (Ext. 28057)</aff>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>03</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <volume>2014</volume>
      <issue>1</issue>
      <elocation-id>M820</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>12</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>02</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2014 by the author; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>The title compound 2-(4-(2-chloroacetamido)-1-methyl-1<italic>H</italic>-pyrrole-2-carboxamido)ethyl acetate was synthesized. The structure of the compound was fully characterized by <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and mass spectral analysis.</p>
      </abstract>
      <kwd-group>
        <kwd>lexitropsins</kwd>
        <kwd>pyrrole-2-carboxamide</kwd>
        <kwd>DNA-alkylating agents</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Lexitropsins, <italic>i.e.</italic>, &#x201C;information reading molecules&#x201D;, such as the crescent-shaped naturally occurring antitumor antibiotic netropsin, bind reversibly with the minor groove of double helical <italic>DNA</italic> to sequences rich with adjacent <italic>AT</italic> base pairs [<xref ref-type="bibr" rid="B1-molbank-2014-M820">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2014-M820">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2014-M820">3</xref>]. These pyrrole carboxamide skeletons have been used as vehicles for delivering anticancer drugs to <italic>DNA</italic> sequences blocking its template function [<xref ref-type="bibr" rid="B4-molbank-2014-M820">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2014-M820">5</xref>]. In the course of our work on the synthesis of lexitropsins [<xref ref-type="bibr" rid="B6-molbank-2014-M820">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2014-M820">7</xref>,<xref ref-type="bibr" rid="B8-molbank-2014-M820">8</xref>,<xref ref-type="bibr" rid="B9-molbank-2014-M820">9</xref>,<xref ref-type="bibr" rid="B10-molbank-2014-M820">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2014-M820">11</xref>], literature search revealed that 1-methyl-1<italic>H</italic>-pyrrole-2-carboxamides carrying an alkylating unit such as a chloroacetamido group at C-4 have not been prepared. Therefore, 2-(4-(2-chloroacetamido)-1-methyl-1<italic>H</italic>-pyrrole-2-carboxamido)ethyl acetate (<bold>5</bold>), a new pyrrole carboxamide possessing an alkylating unit, was prepared as shown in <xref ref-type="scheme" rid="molbank-2014-M820-sch001">Scheme 1</xref>. The product synthesized with a satisfactory yield was fully characterized by nuclear magnetic resonance and mass spectrometry. </p>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>We have synthesized the amide <bold>3</bold> starting from 2-trichloroacetyl-1-methyl-4-nitropyrrole (<bold>1</bold>) [<xref ref-type="bibr" rid="B12-molbank-2014-M820">12</xref>,<xref ref-type="bibr" rid="B13-molbank-2014-M820">13</xref>] according to <xref ref-type="scheme" rid="molbank-2014-M820-sch001">Scheme 1</xref>, in two steps; the first was performed by acyl nucleophilic substitution of the trichloromethyl leaving group by ethanolamine to afford amide <bold>2</bold> and the second by protecting the hydroxyl group with an acetyl group to furnish ester <bold>3</bold> [<xref ref-type="bibr" rid="B14-molbank-2014-M820">14</xref>].</p>
      <p>The chloroacetyl group was then introduced by a sequence of two steps. Reduction of the nitro group in the ester <bold>3</bold> to the corresponding amine <bold>4</bold> was best accomplished in MeOH using H<sub>2</sub>/Pd(C). It is worth noting that amine <bold>4</bold> decomposes easily. Conducting these reactions without degassing furnished the title compound in low yield after tedious purification by column chromatography. Therefore, the solution of <bold>3</bold> in MeOH in the presence of the catalyst was degassed with N<sub>2</sub> prior to the reduction process. After completion of the reaction (by TLC) the reaction mixture was concentrated and then the residue was dissolved in degassed CH<sub>2</sub>Cl<sub>2</sub> containing Et<sub>3</sub>N. Finally, the reaction mixture was concentrated and the title compound <bold>5</bold> was then purified by silica gel chromatography. The required compound <bold>5</bold> obtained in 70% overall yield from <bold>3</bold> was characterized by <sup>1</sup>H-NMR, <sup>13</sup>C-NMR and mass spectral data.</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec id="sec2-molbank-2014-M820">
        <title>2-(4-(2-Chloroacetamido)-1-methyl-1H-pyrrole-2-carboxamido)ethyl Acetate</title>
        <p>A solution of <bold>3</bold> (2.55 g, 10.0 mmol) and Pd/C (0.30 g of 3%) in MeOH (200 mL) was degassed with N<sub>2</sub> for 10 min and then the resulting solution was hydrogenated using Shaker Hydrogenation Apparatus for 3 h at 30 psi. After concentration under reduced pressure, the residue was dissolved in degassed CH<sub>2</sub>Cl<sub>2</sub> (50 mL) containing Et<sub>3</sub>N (2 mL). The resulting mixture was added dropwise to a degassed solution of chloroacetyl chloride (1.68 g, 15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) at 0 &#xB0;C. The reaction mixture was stirred at room temperature for 12 h. The resulting mixture was extracted by EtOAc (2 &#xD7; 100 mL). The combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and concentrated under reduced pressure. The crude product was purified by flash column chromatography (silica gel, 1:3 hexane/EtOAc) to give the title compound <bold>5</bold> (2.10 g, 70%) as a yellow oil. <sup>1</sup>H-NMR (400 MHz, CDCl<sub>3</sub>): &#x3B4; 2.08 (s, 3H), 3.59 (q, <italic>J</italic> = 5.2 Hz, 2H), 3.89 (s, 3H), 4.15 (s, 2H), 4.22 (t, <italic>J</italic> = 5.2 Hz, 2H, O-CH<sub>2</sub>), 6.28 (s, 1H, aromatic-H), 6.56 (d, <italic>J</italic> = 1.5 Hz, 1H, aromatic-H), 7.11 (t, <italic>J</italic> = 1.6 Hz, 1H, NH), 8.17 (s,1H, <italic>N</italic>-H); <sup>13</sup>C-NMR (100 MHz, CDCl<sub>3</sub>): &#x3B4; 20.6, 36.4, 38.5, 42.3, 63.1, 103.2, 118.9, 119.9, 123.2, 161.2, 162.8, 171.1; MS-ESI <italic>m/z</italic> calcd for C<sub>12</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub><sup>35</sup>Cl [M+H]<sup>+</sup> 302.08, found, 302.06. Anal. Calcd. for C<sub>12</sub>H<sub>16</sub>N<sub>3</sub>O<sub>4</sub>Cl: C, 47.77%; H, 5.34%; Cl, 11.75%; N, 13.93%. Found: C, 47.83%; H, 5.41%; N, 13.85%.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2014-M820">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2014-M820-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M820-s001.pdf">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2014-M820-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M820-s002-mod.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2014-M820-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M820-s002.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported by the Deanship of Research at Jordan University of Science and Technology.</p>
    </ack>
    <notes>
      <title>Conflict of Interest</title>
      <p>The author declares no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2014-M820">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmer</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Effects of the antibiotics netropsin and distamycin A on the structure and function of nucleic acids</article-title>
          <source>Prog. Nucleic Acid Res. Mol. Biol.</source>
          <year>1975</year>
          <volume>15</volume>
          <fpage>285</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">1094496</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2014-M820">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lown</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Lexitropsins in antiviral drug development</article-title>
          <source>Antiviral Res.</source>
          <year>1992</year>
          <volume>17</volume>
          <fpage>179</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.1016/0166-3542(92)90040-C</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2014-M820">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arcamone</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Penco</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Orezzi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nicolella</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Pirelli</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Structure and synthesis of distamycin</article-title>
          <source>Nature</source>
          <year>1964</year>
          <volume>203</volume>
          <fpage>1064</fpage>
          <lpage>1065</lpage>
          <pub-id pub-id-type="doi">10.1038/2031064a0</pub-id>
          <pub-id pub-id-type="pmid">14223076</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2014-M820">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rehman</surname>
              <given-names>Z.U.</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Chemistry of DNA minor groove binding agents</article-title>
          <source>J. Photochem. Photobiol. B</source>
          <year>2012</year>
          <volume>115</volume>
          <fpage>105</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jphotobiol.2012.07.003</pub-id>
          <pub-id pub-id-type="pmid">22857824</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2014-M820">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romagnoli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Baraldi</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Iaconinoto</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Carrion</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Tabrizi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>A. Gambari</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Borgatti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Heilmann</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and biological activity of alpha-bromoacryloyl lexitropsin conjugates</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>1123</fpage>
          <lpage>1128</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2005.05.003</pub-id>
          <pub-id pub-id-type="pmid">16006014</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2014-M820">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Shawakfeh</surname>
              <given-names>K.Q.</given-names>
            </name>
          </person-group>
          <article-title>Synthetic studies towards bis-heterodimeric netropsin analogs</article-title>
          <source>Jordan J. Chem.</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>125</fpage>
          <lpage>132</lpage>
        </citation>
      </ref>
      <ref id="B7-molbank-2014-M820">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Klaib</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of a C-2 stapled bis-lexitropsin</article-title>
          <source>Monatsh. Chem.</source>
          <year>2007</year>
          <volume>138</volume>
          <fpage>573</fpage>
          <lpage>577</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-007-0644-z</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2014-M820">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of a terminally linked homodimeric bis-distamycin analog</article-title>
          <source>Monatsh. Chem.</source>
          <year>2006</year>
          <volume>137</volume>
          <fpage>1535</fpage>
          <lpage>1541</lpage>
          <pub-id pub-id-type="doi">10.1007/s00706-006-0547-4</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2014-M820">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Sternbach</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Lown</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Camptothecin and minor-groove binder hybrid molecules: Synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity <italic>in vitro</italic></article-title>
          <source>J. Med. Chem.</source>
          <year>1997</year>
          <volume>40</volume>
          <fpage>216</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="doi">10.1021/jm9605804</pub-id>
          <pub-id pub-id-type="pmid">9003520</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2014-M820">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Oreski</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Lown</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>Design, synthesis and topoisomerase II inhibition activity of 4'-demethylepipodopyllotoxine-lexitropsin conjugate</article-title>
          <source>Anticancer Drug Des.</source>
          <year>1996</year>
          <volume>11</volume>
          <fpage>325</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="pmid">8679055</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2014-M820">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Said</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Lown</surname>
              <given-names>J.W.</given-names>
            </name>
          </person-group>
          <article-title>A convenient synthesis of cross-linked homodimeric lexitropsins</article-title>
          <source>Synth. Comm.</source>
          <year>1995</year>
          <volume>25</volume>
          <fpage>1059</fpage>
          <lpage>1070</lpage>
          <pub-id pub-id-type="doi">10.1080/00397919508012668</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2014-M820">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belanger</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Electrophilic substitutions on 2-trichloroacetylpyrrole</article-title>
          <source>Tetrahedron Lett.</source>
          <year>1979</year>
          <volume>27</volume>
          <fpage>2505</fpage>
          <lpage>2508</lpage>
          <pub-id pub-id-type="doi">10.1016/S0040-4039(01)86333-4</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2014-M820">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rahman</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>P.J.M.</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hartley</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>de la Fuente</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Schatzlein</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pedley</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Pepper</surname>
              <given-names>C.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GC-Targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar <italic>in vitro</italic> cytotoxicity and <italic>in vivo</italic> antitumor activity in mouse models</article-title>
          <source>J. Med. Chem.</source>
          <year>2013</year>
          <volume>56</volume>
          <fpage>2911</fpage>
          <lpage>2935</lpage>
          <pub-id pub-id-type="doi">10.1021/jm301882a</pub-id>
          <pub-id pub-id-type="pmid">23514599</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2014-M820">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Suckling</surname>
              <given-names>C.J.</given-names>
            </name>
          </person-group>
          <article-title>A divergent synthesis of minor groove binders with tail group variation</article-title>
          <source>Org. Biomol. Chem.</source>
          <year>2009</year>
          <volume>7</volume>
          <fpage>178</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="doi">10.1039/B814452D</pub-id>
          <pub-id pub-id-type="pmid">19081961</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2014-M820-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2014-M820-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of 2-(4-(2-chloroacetamido)-1-methyl-1<italic>H</italic>-pyrrole-2-carboxamido)ethyl acetate (<bold>5</bold>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2014-M820-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
